SOLENO THERAPEUTICS INC
DelistedCIK 1484565fmd_01WBX1CPNDCMCNDD0ERXYAJJ3RManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2013 to Mar 31, 2026, 51 periods
Latest annual · FY2025
Millions- Operating income
- 9
- Net income
- 21
- Free cash flow
- 47
Latest quarter · Q1 FY2026
Millions- Total revenues
- 95
- Gross profit
- 93
- Operating income
- 31
- Net income
- 31
- Free cash flow
- 26
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
SOLENO THERAPEUTICS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | $9.4 million | -$187.7 million | 10-K 2026-02-25 · proof | |
| Net income | $20.9 million | -$175.9 million | 10-K 2026-02-25 · proof | |
| Cash from operating activities | $46.8 million | -$69.1 million | 10-K 2026-02-25 · proof | |
| Free cash flow | $46.7 million | -$69.3 million | 10-K 2026-02-25 · proof | |
| Total assets | $563.8 million | $331 million | +70.4% | 10-K 2026-02-25 · proof |
| Total liabilities | $113.7 million | $85.9 million | +32.4% | 10-K 2026-02-25 · proof |
| Cash and cash equivalents | $70.1 million | $87.9 million | -20.3% | 10-K 2026-02-25 · proof |
- What was SOLENO THERAPEUTICS INC's operating income in fiscal 2025?
- SOLENO THERAPEUTICS INC reported operating income of $9.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$187.7 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2026. SEC
- What was SOLENO THERAPEUTICS INC's net income in fiscal 2025?
- SOLENO THERAPEUTICS INC reported net income of $20.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$175.9 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2026. SEC
- What was SOLENO THERAPEUTICS INC's cash from operating activities in fiscal 2025?
- SOLENO THERAPEUTICS INC reported cash from operating activities of $46.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$69.1 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2026. SEC
- What was SOLENO THERAPEUTICS INC's free cash flow in fiscal 2025?
- SOLENO THERAPEUTICS INC reported free cash flow of $46.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$69.3 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2026. SEC
- What are SOLENO THERAPEUTICS INC's total assets?
- As of Dec 31, 2025, SOLENO THERAPEUTICS INC reported total assets of $563.8 million, against $331 million a year earlier (+70.4%). Source: the 10-K filed with the SEC on Feb 25, 2026. SEC
- What are SOLENO THERAPEUTICS INC's total liabilities?
- As of Dec 31, 2025, SOLENO THERAPEUTICS INC reported total liabilities of $113.7 million, against $85.9 million a year earlier (+32.4%). Source: the 10-K filed with the SEC on Feb 25, 2026. SEC
- What are SOLENO THERAPEUTICS INC's cash and cash equivalents?
- As of Dec 31, 2025, SOLENO THERAPEUTICS INC reported cash and cash equivalents of $70.1 million, against $87.9 million a year earlier (-20.3%). Source: the 10-K filed with the SEC on Feb 25, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1484565&period_type=annual&limit=5"Information only, not investment advice.